Modern strategies for optimizing the management of patients with myocardial infarction and atrial fibrillation
DOI:
https://doi.org/10.14739/mmt.2025.1.303513Keywords:
atrial fibrillation, myocardial infarction, cardiac rehabilitationAbstract
The aim of the study – to analyze and summarize information from the scientific literature on modern approaches to the management of patients with acute myocardial infarction and atrial fibrillation, as well as to identify promising directions for research in this category of patients.
Materials and methods. We searched in the scientometric systems of Google Scholar, PubMed, Cochrane Database, conducted a synthesis, comparison, generalization and system-structural analysis of modern scientific literary sources.
Results. The analysis of information in the modern scientific literature demonstrates that patients with combined cardiovascular pathology, in particular acute myocardial infarction with atrial fibrillation (AF), have a higher risk of mortality, a higher frequency of repeated cardiovascular events and a severe course of the underlying disease, which complicates the management of this category of patients. Despite all efforts to improve the AF management system, in the last decade the incidence of AF continues to grow, the age of patients is decreasing, the number of patients with two or more cardiovascular disease risk factors rises, which increases the frequency of AF-related complications. The use of mobile applications to solve clinical tasks in patients with AF has proven its effectiveness and is actively used in practice. Among the components of myocardial infarction and AF management, revascularization, drug treatment and rehabilitation have the highest level of evidence and significantly reduce mortality. It should be noted that existing rehabilitation protocols do not include restorative treatment programs for patients with combined cardiovascular pathology. Different rehabilitation strategies for myocardial infarction and atrial fibrillation create difficulties in managing these pathologies in combination.
Conclusions. Optimizing the management of patients with myocardial infarction and atrial fibrillation through the development of rehabilitation programs will help unify the approach to this category of patients. The use of telemedicine elements for rehabilitation treatment will expand the limits of patients’ access to cardiac rehabilitation resources, increase their adherence and improve treatment effectiveness.
References
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716-99. doi: https://doi.org/10.1093/eurheartj/ehz859
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 2020;76:2982-3021. doi: https://doi.org/10.1016/j.jacc.2023.11.007
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-21. doi: https://doi.org/10.1177/1747493019897870. Erratum in: Int J Stroke. 2020;15(9):NP11-NP12. doi: https://doi.org/10.1177/1747493020905964
Cottin Y, Maalem Ben Messaoud B, Monin A, Guilleminot P, Bisson A, Eicher J-C, et al. Temporal relationship between atrial fibrillation and heart failure development analysis from a nationwide database. J Clin Med. 2021;10:5101. doi: https://doi.org/10.3390/jcm10215101
Sadat B, Al Taii H, Sabayon M, Narayanan CA. Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations. Curr Cardiol Rep. 2024;26(5):313-23. doi: https://doi.org/10.1007/s11886-024-02040-7
Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-826. doi: https://doi.org/10.1093/eurheartj/ehad191. Erratum in: Eur Heart J. 2024;45(13):1145. doi: https://doi.org/10.1093/eurheartj/ehad870
Soliman EZ, Rahman AF, Zhang ZM, Rodriguez CJ, Chang TI, Bates JT, et al. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation. Hypertension. 2020;75(6):1491-6. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.14766
Van den Dries CJ, van Doorn S, Rutten FH, Oudega R, van de Leur S, Elvan A, et al. Integrated management of atrial fibrillation in primary care: results of the ALL-IN clus ter randomized trial. Eur Heart J. 2020;41:2836-44. doi: https://doi.org/10.1093/eurheartj/ehaa055
Zakeri R, Morgan AD, Sundaram V, Bloom C, Cleland JGF, Quint JK. Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Med. 2021;19(1):179. doi: https://doi.org/10.1186/s12916-021-02048-8
Brady PF, Chua W, Nehaj F, Connolly DL, Khashaba A, Purmah YJV, et al. Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death. J Am Heart Assoc. 2022;11(4):e022833. doi: https://doi.org/10.1161/JAHA.121.022833
Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1261-74. doi: https://doi.org/10.1001/jama.2019.0693
Bunting KV, Van Gelder IC, Kotecha D. STEEER-AF: a cluster-randomized education trial from the ESC. Eur Heart J. 2020;41:1952-4. doi: https://doi.org/10.1093/eurheartj/ehaa421
Belkouche A, Yao H, Putot A, Chagué F, Rochette L, Danchin N, et al. The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review. J Clin Med. 2021;10(2):198. doi: https://doi.org/10.3390/jcm10020198
Akao M, Shimizu W, Atarashi H, Ikeda T, Inoue H, Okumura K, et al. Oral anticoagulant use in elderly Japanese patients with non-valvular atrial fibrillation: Subanalysis of the ANAFIE Registry. Circ Rep. 2020;2(10):552-9. doi: https://doi.org/10.1253/circrep.cr-20-0082
Elbadawi A, Sedhom R, Gad M, Hamed M, Elwagdy A, Barakat AF, et al. Screening for atrial fibrillation in the elderly: a network meta-analysis of randomized trials. Eur J Intern Med. 2022;105:38-45. doi: https://doi.org/10.1016/j.ejim.2022.07.015
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. doi: https://doi.org/10.1093/eurheartj/ehaa612
Harskamp RE, Fanaroff AC, Lopes RD, Wojdyla DM, Goodman SG, Thomas LE, et al. Antithrombotic therapy in patients with atrial fibrillation after acute coronary syn dromes or percutaneous intervention. J Am Coll Cardiol. 2022;79(5):417-27. doi: https://doi.org/10.1016/j.jacc.2021.11.035
Alexander JH, Wojdyla D, Vora AN, Thomas L, Granger CB, Goodman SG, et al. Risk/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS. Circulation 2020;141(20):1618-27. doi: https://doi.org/10.1161/circulationaha.120.046534
Proietti M, Vitolo M, Harrison SL, Lane DA, Fauchier L, Marin F, et al. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry. Clin Res Cardiol Off J Ger Card Soc. 2022;111(1):70-84. doi: https://doi.org/10.1007/s00392-021-01914-y
Bodin A, Bisson A, Gaborit C, Herbert J, Clementy N, Babuty D, et al. Ischemic stroke in patients with sinus node disease, atrial fibrillation, and other cardiac conditions. Stroke. 2020;51(6):1674-81. doi: https://doi.org/10.1161/strokeaha.120.029048
Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, et al. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. JAMA Cardiol. 2020;5(5):582-589. doi: https://doi.org/10.1001/jamacardio.2019.6175
Ko D, Benson MD, Ngo D, Yang Q, Larson MG, Wang TJ, et al. Proteomics profiling and risk of new-onset atrial fibrillation: Framingham heart study. J Am Heart Assoc. 2019;8(6):e010976. doi: https://doi.org/10.1161/jaha.118.010976
Kaikita K, Yasuda S, Akao M, Ako J, Matoba T, Nakamura M, et al. Bleeding and subsequent cardiovascular events and death in atrial fibrillation with stable coronary artery disease: Insights from the AFIRE Trial. Circ Cardiovasc Interv. 2021;14(11):e010476. doi: https://doi.org/10.1161/CIRCINTERVENTIONS.120.010476
Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, et al. Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction. J Am Heart Assoc. 2021;10(18):e021417. doi: https://doi.org/10.1161/JAHA.121.021417
Mokgokong R, Schnabel R, Witt H, Miller R, Lee TC. Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries. PLoS One. 2022;17(7):e0269867. doi: https://doi.org/10.1371/journal.pone.0269867
Pinho-Gomes AC, Azevedo L, Copland E, Canoy D, Nazarzadeh M, Ramakrishnan R, et al. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis. PLoS Med. 2021;18(6):e1003599. doi: https://doi.org/10.1371/journal.pmed.1003599
Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GY. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. Mayo Clin Proc. 2019;94(7):1261-7. doi: https://doi.org/10.1016/j.mayocp.2018.10.022
Yoon M, Yang PS, Jang E, Yu HT, Kim TH , Uhm JS, et al. Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care management: a nationwide cohort study. Thromb Haemost. 2019;119(10):1695-703. doi: https://doi.org/10.1055/s-0039-1693516
Ugowe FE, Jackson LR 2nd. Atrial fibrillation and mortality risk: seeing the big picture. Eur Heart J Qual Care Clin Outcomes. 2019;5(1):6-7. doi: https://doi.org/10.1093/ehjqcco/qcy050
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-337. doi: https://doi.org/10.1093/eurheartj/ehab484. Erratum in: Eur Heart J. 2022;43(42):4468. doi: https://doi.org/10.1093/eurheartj/ehac458
Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015;128(5):509-18.e2. doi: https://doi.org/10.1016/j.amjmed.2014.11.026
Dibben GO, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, et al. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J. 2023;44(6):452-469. doi: https://doi.org/10.1093/eurheartj/ehac747
Scherrenberg M, Falter M, Dendale P. Cost-effectiveness of cardiac telerehabilitation in coronary artery disease and heart failure patients: systematic review of randomized controlled trials. Eur Heart J Digit Health. 2020;1(1):20-9. doi: https://doi.org/10.1093/ehjdh/ztaa005
Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021;28(5):460-95. doi: https://doi.org/10.1177/2047487320913379
Dibben G, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler A-D, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2021;11(11):CD001800. doi: https://doi.org/10.1002/14651858.CD001800.pub4
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Levytska L. V., Dmyterko U. A.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
